|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300074662 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-11 16:05:52 |
|
注册时间: Date of Registration: |
2023-08-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
经筋理论诊疗非特异性慢性颈痛伴功能障碍的临床疗效观察 |
|
Public title: |
Clinical observation on the therapeutic effect of the meridian theory in the diagnosis and treatment of non-specific chronic neck pain with dysfunction |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
经筋理论诊疗非特异性慢性颈痛伴功能障碍的临床疗效观察 |
|
Scientific title: |
Clinical observation on the therapeutic effect of the meridian theory in the diagnosis and treatment of non-specific chronic neck pain with dysfunction |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈沁涛 |
研究负责人: |
李江山 |
|
Applicant: |
Qintao Chen |
Study leader: |
Jiangshan Li |
|
申请注册联系人电话: Applicant telephone: |
+86 157 0079 2616 |
研究负责人电话:
Study leader's |
+86 137 0731 5642 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
429587419@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
001316@hnucm.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖南省长沙市开福区蔡锷北路233号 |
研究负责人通讯地址: |
湖南省长沙市开福区蔡锷北路233号 |
|
Applicant address: |
233 CAI'e Road North,Kaifu District,Changsha,Hunan,China |
Study leader's address: |
233 CAI'e Road North,Kaifu District,Changsha,Hunan,China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
湖南中医药大学第二附属医院 |
||
|
Applicant's institution: |
The Second Affiliated Hospital of Hunan University of Chinese Medicine |
||
|
研究负责人所在单位: |
湖南中医药大学第二附属医院 |
||
|
Affiliation of the Leader: |
The Second Affiliated Hospital of Hunan University of Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023-KY-027 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
湖南中医药大学第二附属医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of the Second Affiliated Hospital of the Hunan University of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-14 00:00:00 | ||
|
伦理委员会联系人: |
杨声辉 |
||
|
Contact Name of the ethic committee: |
Shenghui Yang |
||
|
伦理委员会联系地址: |
湖南省长沙市开福区蔡锷北路233号 |
||
|
Contact Address of the ethic committee: |
233 CAI'e Road North,Kaifu District,Changsha,Hunan,China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 731 8491 7719 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
湖南中医药大学第二附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Second Affiliated Hospital of Hunan University of Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市开福区蔡锷北路233号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
233 CAI'e Road North,Kaifu District,Changsha,Hunan,China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
湖南省科技创新计划资助(2022RC1221) |
||||||||||||||||||||||
|
Source(s) of funding: |
Funded by Hunan Science and Technology Innovation program(2022RC1221) |
||||||||||||||||||||||
|
研究疾病: |
非特异性慢性颈痛 |
||||||||||||||||||||||
|
Target disease: |
Nonspecific chronic neck pain |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本试验的目的是评估经筋远端推拿是否对功能障碍具有更为显著的疗效。本研究将为临床医生和利益相关者提供急需的知识,为伴有功能障碍的非特异性慢性颈痛患者提供补充和替代治疗。 |
||||||||||||||||||||||
|
Objectives of Study: |
The aim of this study was to assess whether distal jingjin massage has a more significant effect on functional disorders. This study will provide much-needed knowledge for clinicians and stakeholders to provide complementary and alternative therapies for patients with nonspecific chronic neck pain with functional impairment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①以颈痛症状病程至少3个月但不超过2年; ②疼痛发作时间超过30分钟,每月至少发生一次; ③招募时通过视觉模拟量表(VAS)测量的疼痛强度超过3分; ④颈椎活动时感到疼痛,或颈部活动受限; ⑤年龄20-60岁,男女不限; ⑥能够并愿意服从干预和随访评估; ⑦同意在治疗期间不接受其他相关治疗(包括肌松药); ⑧能够提供书面知情同意书; ⑨招募前7天内未接受按摩或其他相关治疗 |
||||||||||||||||||||||
|
Inclusion criteria |
① The course of neck pain symptoms should be at least 3 months but not more than 2 years; ② Pain attacks lasting for more than 30 minutes, occurring at least once a month; ③ The pain intensity measured through the Visual Analog Scale (VAS) during recruitment exceeded 3 points; ④ Feeling pain during cervical movement or limited neck movement; ⑤ Age range from 20 to 60 years old, regardless of gender; ⑥ Able and willing to comply with interventions and follow-up evaluations; ⑦ Agree not to receive other related treatments (including muscle relaxants) during the treatment period; ⑧ Able to provide written informed consent; ⑨ Did not receive massage or other related treatment within 7 days before recruitment |
||||||||||||||||||||||
|
排除标准: |
①有伴神经症状的颈椎间盘突出史;颈部创伤;外科颈部骨折;脊柱疾病;感染性炎症性自身免疫性疾病;先天性椎体畸形;或者压缩性骨折; ②有严重的原发病,如心脑血管、肝、肾疾病; ③由于与严重神经症或痴呆相关的精神或心理障碍,无法沟通或自我照顾; ④孕妇或哺乳期妇女; ⑤局部皮肤损伤; ⑥没有在规定的时间内坚持治疗; ⑦参与其他临床试验; ⑧使用任何其他治疗方法(药物或非药物) |
||||||||||||||||||||||
|
Exclusion criteria: |
① Have a history of cervical disc herniation with neurological symptoms; Neck trauma; Surgical neck fracture; Spinal diseases; Infectious inflammatory autoimmune diseases; Congenital vertebral malformation; Or compression fractures; ② There are serious primary diseases, such as cardiovascular, cerebrovascular, liver, and kidney diseases; ③ Unable to communicate or take care of oneself due to mental or psychological disorders related to severe neurosis or dementia; ④ Pregnant or lactating women; ⑤ Local skin damage; ⑥ Failure to adhere to treatment within the prescribed time frame; ⑦ Participate in other clinical trials; ⑧ Use any other treatment method (medication or non medication) |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-08-13 00:00:00至 To 2024-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-13 00:00:00 至 To 2024-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
在招募之前将生成连续数字列表(从1-160),并且这些数字中的每一个将被随机分配到两个研究组(对照组、干预组)中的一个。随机化列表由Excel生成。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A list of consecutive numbers (from 1 to 160) is generated prior to recruitment, and each of these numbers will be randomly assigned to one of the two study groups (control, intervention) . The randomization list is generated by Excel. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
患者将被告知他们将接受的治疗类型。治疗师将知道分配情况,以便他们应该学习如何与患者沟通以确保治疗的盲法。为了降低偏倚风险,评估人员,数据管理人员和统计人员将不知道结果评估程序和数据分析中的小组任务。 |
|
Blinding: |
Patients will be told the type of treatment they will receive. Therapists will know the assignments so that they should learn how to communicate with patients to ensure treatment blindness. To reduce the risk of bias, evaluators, data managers, and statisticians will be unaware of the results assessment procedures and team assignments in data analysis. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
以论文形式公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
public paper |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |